·HSK 4

Novo Nordisk (pharmaceutical company)
Nuòhé Nuòdé
诺和诺德
with
yǔ
与
OpenAI (AI company)
OpenAI
OpenAI
to cooperate / partnership
hézuò
合作
will (future marker)
jiāng
将
artificial intelligence / AI
réngōng zhìnéng
人工智能
to integrate into / to embed in
róngrù
融入
drugs / medicine
yàowù
药物
research and development / R&D
yánfā
研发
entire process / end-to-end workflow
quán liúchéng
全流程
。

Denmark

Dānmài

丹麦

pharmaceutical / drug manufacturing

zhìyào

制药

company

gōngsī

公司

Novo Nordisk

Nuòhé Nuòdé

诺和诺德

with

yǔ

与

OpenAI (AI company)

OpenAI

to reach / to achieve

dáchéng

达成

strategic / strategy

zhànlüè

战略

cooperation / partnership

hézuò

合作

，

will (future marker)

jiāng

将

artificial intelligence / AI

réngōng zhìnéng

人工智能

to integrate into / to embed in

róngrù

融入

drug research and development

yàowù yánfā

药物研发

、

production / manufacturing

shēngchǎn

生产

and

hé

和

supply chain

gōngyìng liàn

供应链

entire process / end-to-end workflow

quán liúchéng

全流程

。

cooperation / partnership

hézuò

合作

key focus / priority

zhòngdiǎn

重点

is / to be

shì

是

to accelerate / to speed up

jiāsù

加速

to discover / discovery

fāxiàn

发现

obesity

féipàngzhèng

肥胖症

and

hé

和

diabetes

tángniàobìng

糖尿病

new treatments / new therapies

xīn liáofǎ

新疗法

，

full / comprehensive

quánmiàn

全面

deployment / to deploy

bùshǔ

部署

plan / planned

jìhuà

计划

by (formal time marker)

yú

于

end of 2026

2026 nián dǐ

2026年底

to complete / to finish

wánchéng

完成

。

May 4, 2026 at 10:50 AM

Denmark

Dānmài

丹麦

pharmaceutical / drug manufacturing

zhìyào

制药

giant / major player

jùtóu

巨头

Novo Nordisk (pharmaceutical company)

Nuòhé Nuòdé

诺和诺德

to announce / to declare

xuānbù

宣布

with

yǔ

与

OpenAI (AI company)

OpenAI

to establish / to form

jiànlì

建立

strategic / strategy

zhànlüè

战略

cooperation / partnership

hézuò

合作

partnership / partner relationship

huǒbàn guānxi

伙伴关系

。

both parties / the two sides

shuāngfāng

双方

to plan / plan

jìhuà

计划

will (future marker)

jiāng

将

artificial intelligence / AI

réngōng zhìnéng

人工智能

technology / techniques

jìshù

技术

to integrate into / to embed in

róngrù

融入

company

gōngsī

公司

from

cóng

从

drug research and development

yàowù yánfā

药物研发

to / through

dào

到

production / manufacturing

shēngchǎn

生产

and

hé

和

supply chain

gōngyìng liàn

供应链

management

guǎnlǐ

管理

(attributive particle)

的

entire process / end-to-end workflow

quán liúchéng

全流程

。

cooperation

hézuò

合作

key focus / priority

zhòngdiǎn

重点

one of (the)

zhī yī

之一

is / to be

shì

是

to accelerate / to speed up

jiāsù

加速

to discover / discovery

fāxiàn

发现

new type / novel

xīnxíng

新型

obesity

féipàngzhèng

肥胖症

and

hé

和

diabetes

tángniàobìng

糖尿病

treatment / to treat

zhìliáo

治疗

program / solution

fāng an

方案

。

Novo Nordisk

Nuòhé Nuòdé

诺和诺德

to state / to indicate

biǎoshì

表示

，

this time / this

cǐ cì

此次

cooperation / partnership

hézuò

合作

to aim at / with the goal of

zhǐzài

旨在

to enhance / to strengthen

zēngqiáng

增强

scientists

kēxuéjiā

科学家

(possessive particle)

的

research

yánjiū

研究

capabilities / ability

nénglì

能力

，

rather than / not

ér fēi

而非

to replace / to substitute

qǔdài

取代

them / they

tāmen

他们

。

according to / in accordance with

ànzhào

按照

plan / the plan

jìhuà

计划

，

full / comprehensive

quánmiàn

全面

deployment / to deploy

bùshǔ

部署

will

jiāng

将

by (formal time marker)

yú

于

end of 2026

2026 nián dǐ

2026年底

to complete / to finish

wánchéng

完成

。

artificial intelligence / AI

réngōng zhìnéng

人工智能

currently (progressive marker)

zhèng

正

increasingly more / more and more

yuè lái yuè duō

越来越多

(adverbial particle)

地

(passive marker)

bèi

被

pharmaceutical / drug manufacturing

zhìyào

制药

companies

gōngsī

公司

to be used for

yòngyú

用于

to improve / to raise

tígāo

提高

new drugs

xīn yào

新药

research and development / R&D

yánfā

研发

efficiency

xiàolǜ

效率

。

New Words

Dānmài zhìyào jùtóu

丹麦制药巨头

Danish pharmaceutical giant

zhànlüè hézuò

战略合作

strategic partnership

róngrù

融入

to integrate

yàowù yánfā

药物研发

drug R&D

shēngchǎn gōngyìng liàn

生产供应链

production supply chain

féipàngzhèng hé tángniàobìng

肥胖症和糖尿病

obesity and diabetes

zēngqiáng nénglì

增强能力

to enhance capability

qǔdài

取代

to replace

bùshǔ

部署

deployment

yánfā xiàolǜ

研发效率

R&D efficiency

News in English

Science & Technology

Novo Nordisk Partners With OpenAI to Integrate AI Across Drug Discovery Pipeline

Danish pharmaceutical company Novo Nordisk has partnered with OpenAI to integrate AI across its drug discovery, manufacturing, and supply chain operations. The collaboration focuses on accelerating new treatments for obesity and diabetes, with full deployment planned by end of 2026.

Danish pharmaceutical giant Novo Nordisk announced a strategic partnership with OpenAI. The two parties plan to integrate AI technology into the company's entire process from drug research and development to production and supply chain management. One key focus of the cooperation is to accelerate the discovery of novel obesity and diabetes treatment solutions. Novo Nordisk stated that this cooperation aims to enhance scientists' research capabilities rather than replace them. According to plans, comprehensive deployment will be completed by the end of 2026. Artificial intelligence is increasingly being used by pharmaceutical companies to improve the efficiency of new drug research and development.

New Words

News in English

Novo Nordisk Partners With OpenAI to Integrate AI Across Drug Discovery Pipeline

More in Science & Technology